PlainRecalls
FDA Drug Moderate Class II Terminated

Fluoxetine Capsules USP, 10 mg, in 100-count bottles, Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland, Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960. NDC 50111-647-01

Reported: May 6, 2015 Initiated: April 13, 2015 #D-0970-2015

Product Description

Fluoxetine Capsules USP, 10 mg, in 100-count bottles, Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland, Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960. NDC 50111-647-01

Reason for Recall

Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.

Details

Recalling Firm
Teva Pharmaceuticals USA
Distribution
Nationwide
Location
Horsham, PA

Frequently Asked Questions

What product was recalled?
Fluoxetine Capsules USP, 10 mg, in 100-count bottles, Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland, Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960. NDC 50111-647-01. Recalled by Teva Pharmaceuticals USA.
Why was this product recalled?
Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 6, 2015. Severity: Moderate. Recall number: D-0970-2015.